Carboplatin Injection · 1,232 days since initial FDA posting
Brand: CARBOPLATIN
FDA lists Carboplatin Injection as Active Shortage (Gland Pharma Limited).
Availability on file: Limited Availability
Carboplatin Injection: Active Shortage
Limited Availability Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Carboplatin Injection
- Manufacturer
- Gland Pharma Limited
- Dosage Form
- Injection
- Presentation
- Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01)
- Package NDC
- 54288-165-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Limited Availability
- First Reported
- Apr 28, 2023
- Last Updated
- Sep 29, 2025
- Therapeutic Category
- Oncology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Estimated recovery: Q4 2025; Distributed by BPI Labs, LLC
Nearby, Other Carboplatin Shortage Records
Carboplatin Injection
Gland Pharma Limited
Injection
Carboplatin Injection
Gland Pharma Limited
Injection
Carboplatin Injection
Gland Pharma Limited
Injection
Carboplatin Injection
Teyro Labs
Injection
Carboplatin Injection
Teyro Labs
Injection
Carboplatin Injection
Teyro Labs
Injection
FDA reason on file: Estimated recovery: Q4 2025; Distributed by BPI Labs, LLC. General shortage guidance lives on the tracker hub.